Please login to the form below

Not currently logged in

Pollinex Quattro

This page shows the latest Pollinex Quattro news and features for those working in and with pharma, biotech and healthcare.

Allergy Tx hit hard as birch pollen product stumbles

Allergy Tx hit hard as birch pollen product stumbles

The trial started in 2017 and was designed to test the efficacy of the Pollinex Quattro Birch on the symptoms of allergic rhino-conjunctivitis due to birch pollen, as well as ... Two phase 2 studies revealed a significant 32% reduction in allergic

Latest news

  • Positive mid-stage trial gives Allergy’s investors some welcome relief Positive mid-stage trial gives Allergy’s investors some welcome relief

    All of the doses were safe and well-tolerated in the 447-patient study, according to Allergy, which was hit hard 11 years ago when the FDA placed its Pollinex Quattro

  • Leaning forward

    The company's flagship product is Pollinex Quattro, which is transforming immunotherapy by vaccinating against allergy with only four injections. ... A more structured process for classifying and resolving incidents.  . Pollinex Quattro allergy vaccine.

  • Yo-yoing

    R204, which marks an important step in the development of Pollinex Quattro for ragweed allergy.

  • Time for a tumble

    progress made in clinical trials, particularly that of lead product, Pollinex Quattro, a four-shot vaccination for allergy sufferers.

  • Hitting the highs and lows

    Allergy Therapeutics makes a hayfever vaccine Pollinex Quattro in Europe on a 'named patient basis'. ... Pollinex Quattro improves on this as the treatment is delivered in just four injections.

More from news
Approximately 1 fully matching, plus 6 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

Could formulary intelligence be your brand differentiator?
Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...
Lara Meyer
How COVID-19 is accelerating the threat of antimicrobial resistance
Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19...
Improve clinical trials through patient journey mapping
Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...